Author

Mattias Kaspar Krõlov

University of Tartu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Andres SalumetsiD· 1 shared Darja LavõginaiD· 1 shared Hans VellamaiD· 1 shared Helen Lust· 1 shared Jana JaaliD· 1 shared Kattri‐Liis EsklaiD· 1 shared Valentina Di NisioiD· 1 shared Vijayachitra ModhukuriD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andres SalumetsORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyScientific ReportsPeer-reviewedFeb 21, 2024

Inhibition of epigenetic and cell cycle-related targets in glioblastoma cell lines: onametostat reduces proliferation and viability in both normoxic and hypoxic conditions

Darja Lavõgina, Mattias Kaspar Krõlov, Hans Vellama…·Jana Jaal

This study evaluates the efficacy of onametostat, a PRMT5 inhibitor, in reducing glioblastoma cell proliferation and viability under normoxic and hypoxic conditions.

6 citations

humanbulk RNA-seq

𝕏 PostBluesky